Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours.

There was a trend toward more frequent expression in the epithelium of malignant tumours (71.4%) compared to benign (54.3%) although this failed to reach statistical significance ( Table 1 ).

also in 6,035 other papers